Skip to main content
. 2021 Apr 26;14:70. doi: 10.1186/s13045-021-01076-4

Fig. 7.

Fig. 7

Fatty acid oxidation of de novo and relapsed primary AML cells treated with VEN/8-Cl-Ado and VEN/AZA versus control. Fatty acid oxidation of de novo (a) and relapsed (b) primary AML cells treated for 24 h with 10 nM VEN plus 500 nM 8-Cl-Ado or 10 nM VEN plus 5 µM AZA